CVS Settles Opioid Case

CVS PharmacyCVS PharmacyU.S. pharmacy chain and its subsidiaries agreed to pay $315 million to settle federal claims over opioid and other controlled-substance prescriptions. The deal requires CVS to add safeguards, including proactive monitoring of opioid prescribing patterns. The settlement resolves a 2024 Justice DepartmentDepartment of JusticeUnited States federal executive department lawsuit alleging CVS filled prescriptions without a legitimate medical purpose and sought federal reimbursement for many of them. The case is part of federal efforts tied to the U.S. opioid addiction and overdose crisis. CVS said its pharmacists are trained in safe medication use and have programs to guide patient decisions. The Justice Department alleged CVS ignored warning signs; CVS strongly disagreed and admitted no wrongdoing.